Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Ceftriaxone 1g Powder for solution for injection or infusion - PA0281/225/001
- Cimeldine 400mg Film Coated Tablet - PA0126/077/002
- Desferal 500mg Vials Powder for Solution for Injection or Powder for Concentrate for Solution for Infusion - PA0896/008/001
- Doxatan 2mg Tablet - PA0126/202/002
- Imodium Plus 2mg/125mg Tablets - PA0281/225/001
- Spasmonal Forte 120mg Hard Capsules - PA2010/043/002
- Tipol 125mg Suppository - PA0126/331/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Claforan Powder for Solution for Injection 1g - PA0540/037/003
- Germentin 125mg/31.25mg per 5ml Powder for Oral Suspension - PA0577/034/002
- Lercanidipine Clonmel 20mg Tablets - PA0126/187/002
- Losartan Rowa 100mg Film Coated Tablets - PA0074/082/003
- Pinamox 500mg Capsules - PA0298/010/004
- Pravastatin Sodium 40mg Tablets - PA0436/046/003
- RoActemra 162mg Solution for Injection in Pre Filled Pen - EU/1/08/492/009-10
- Sirdupla 25mcg/125mcg per Metered Dose Pressurised Inhalation, Suspension - PA0577/201/001
- Tenofovir disoproxil Mylan 245mg Film Coated Tablet - EU/1/16/1129/001
- Zerbaxa 1g/0.5g Powder for Concentrate for Solution for Infusion - EU/1/15/1032/001
- Zyban 150mg Prolonged Release Tablets - PA1077/017/001
Please see the shortages section of the HPRA website for further information.
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.